Halozyme Therapeutics shares owned by Jpmorgan Chase & Co
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Jpmorgan Chase & Co
from 13F filings
Historical chart of Jpmorgan Chase & Co investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Jpmorgan Chase & Co consolidated in one spreadsheet with up to 7 years of data
Download as csv

Quarterly reported holdings in Halozyme Therapeutics by Jpmorgan Chase & Co
Quarter filed | Position value | Share count | Share price at filing |
---|---|---|---|
2024-12-31 | $7.4M | 7.7M | 0.95 |
2024-09-30 | $6.1M | 6.0M | 1.00 |
2024-06-30 | $5.3M | 5.6M | 0.95 |
2024-03-31 | $9.0M | 10M | 0.89 |
2023-12-31 | $8.1M | 9.4M | 0.86 |
2023-09-30 | $9.6M | 11M | 0.85 |
2023-06-30 | $13M | 16M | 0.83 |
2023-03-31 | $13M | 15M | 0.83 |
2022-12-31 | $11M | 12M | 0.97 |
2022-06-30 | $7.7M | 8.7M | 0.89 |
2022-03-31 | $7.7M | 8.7M | 0.88 |